Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Airway Management During Deep Sedation in Hysteroscopy

NCT: NCT05701839 · COMPLETED

NCT IDNCT05701839
StatusCOMPLETED
Start Date2023-02-01
Completion2023-09-30

Brief Summary

Hysteroscopy is used to examine and treat uterine diseases. Because of severe pain due to uterine distention and cervical dilatation, deep sedation usually be provided during this procedure. Respiratory depression and upper airway obstruction are main respiratory complications during deep sedation. Face mask and nasopharyngeal airway are main airway management during deep sedation. Oxygen reserve index is a non-invasive parameter, it reflects the moderate hyperoxia statues. In this study, investigators compare the effect of face mask and nasopharyngeal airway management on oxygenation during deep sedation in participants undergoing hysteroscopy. Investigators also investigate whether oxygen reserve index monitoring reduce the incidence of hypoxemia.

Frequently Asked Questions

What is Airway Management During Deep Sedation in Hysteroscopy?

Airway Management During Deep Sedation in Hysteroscopy is a clinical trial registered under NCT05701839. Current status: COMPLETED.

What is the status of NCT05701839?

The current status of NCT05701839 (Airway Management During Deep Sedation in Hysteroscopy) is: COMPLETED.

When did Airway Management During Deep Sedation in Hysteroscopy start?

Airway Management During Deep Sedation in Hysteroscopy started on 2023-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.